Authors:
REWERS M
ZACCARO D
SZENTENDREI T
RICH S
ROBBINS DC
Citation: M. Rewers et al., APO-E AND APO A-IV PHENOTYPES AND CAROTID-ARTERY WALL THICKNESS IN TYPE-2 DIABETIC AND NONDIABETIC PERSONS, Diabetes, 47, 1998, pp. 608-608
Authors:
KOVACS B
SZENTENDREI T
BEDNAREK JM
PIERSON MC
MOUNTZ JD
VOGELGESANG SA
TSOKOS GC
Citation: B. Kovacs et al., PERSISTENT EXPRESSION OF A SOLUBLE FORM OF FAS APO1 IN CONTINUOUSLY ACTIVATED T-CELLS FROM A PATIENT WITH SLE/, Clinical and experimental rheumatology, 15(1), 1997, pp. 19-23
Authors:
TSOKOS M
VASSILOPOULOS D
SZENTENDREI T
QUEZADO M
KARAMERIS A
TSOKOS G
Citation: M. Tsokos et al., FAS-MEDIATED APOPTOSIS IN PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR (PNET) EWINGS-SARCOMA (ES), The FASEB journal, 10(6), 1996, pp. 55-55
Authors:
PEREZJIMENEZ O
KAPUR J
SZENTENDREI T
BEDNAREK J
SJOGREN MH
Citation: O. Perezjimenez et al., HEPATITIS-C VIRUS (HCV) GENOTYPE CHANGE AFTER TREATMENT WITH INTERFERON-ALPHA-2B (INF-ALPHA-2B), Hepatology, 24(4), 1996, pp. 1738-1738
Citation: T. Szentendrei et al., BETA-ADRENERGIC-RECEPTOR EXPRESSION IS REGULATED BY CYTOKINES IN HUMAN B-LYMPHOCYTES, The Journal of immunology, 150(8), 1993, pp. 183-183